SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Humphreys K) "

Sökning: WFRF:(Humphreys K)

  • Resultat 51-60 av 236
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  •  
52.
  • Johnatty, S. E., et al. (författare)
  • No evidence that GATA3 rs570613 SNP modifies breast cancer risk
  • 2009
  • Ingår i: Breast Cancer Research and Treatment. - : Springer. - 0167-6806 .- 1573-7217. ; 117:2, s. 371-379
  • Tidskriftsartikel (refereegranskat)abstract
    • GATA-binding protein 3 (GATA3) is a transcription factor that is crucial to mammary gland morphogenesis and differentiation of progenitor cells, and has been suggested to have a tumor suppressor function. The rs570613 single nucleotide polymorphism (SNP) in intron 4 of GATA3 was previously found to be associated with a reduction in breast cancer risk in the Cancer Genetic Markers of Susceptibility project and in pooled analysis of two case-control studies from Norway and Poland (P trend = 0.004), with some evidence for a stronger association with estrogen receptor (ER) negative tumours [Garcia-Closas M et al. (2007) Cancer Epidemiol Biomarkers Prev 16:2269-2275]. We genotyped GATA3 rs570613 in 6,388 cases and 4,995 controls from the Breast Cancer Association Consortium (BCAC) and 5,617 BRCA1 and BRCA2 carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). We found no association between this SNP and breast cancer risk in BCAC cases overall (ORper-allele = 1.00, 95% CI 0.94-1.05), in ER negative BCAC cases (ORper-allele = 1.02, 95% CI 0.91-1.13), in BRCA1 mutation carriers RRper-allele = 0.99, 95% CI 0.90-1.09) or BRCA2 mutation carriers (RRper-allele = 0.93, 95% CI 0.80-1.07). We conclude that there is no evidence that either GATA3 rs570613, or any variant in strong linkage disequilibrium with it, is associated with breast cancer risk in women. 
  •  
53.
  •  
54.
  •  
55.
  •  
56.
  •  
57.
  •  
58.
  •  
59.
  •  
60.
  • Chalmers, J. R., et al. (författare)
  • Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
  • 2018
  • Ingår i: British Journal of Dermatology. - : John Wiley & Sons. - 0007-0963 .- 1365-2133. ; 178:5, s. E332-E341
  • Tidskriftsartikel (refereegranskat)abstract
    • This is the report from the fifth meeting of the Harmonising Outcome Measures for Eczema initiative (HOME V). The meeting was held on 12-14 June 2017 in Nantes, France, with 81 participants. The main aims of the meeting were (i) to achieve consensus over the definition of the core domain of long-term control and how to measure it and (ii) to prioritize future areas of research for the measurement of the core domain of quality of life (QoL) in children. Moderated whole-group and small-group consensus discussions were informed by presentations of qualitative studies, systematic reviews and validation studies. Small-group allocations were performed a priori to ensure that each group included different stakeholders from a variety of geographical regions. Anonymous whole-group voting was carried out using handheld electronic voting pads according to pre-defined consensus rules. It was agreed by consensus that the long-term control domain should include signs, symptoms, quality of life and a patient global instrument. The group agreed that itch intensity should be measured when assessing long-term control of eczema in addition to the frequency of itch captured by the symptoms domain. There was no recommendation of an instrument for the core outcome domain of quality of life in children, but existing instruments were assessed for face validity and feasibility, and future work that will facilitate the recommendation of an instrument was agreed upon.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 51-60 av 236
Typ av publikation
tidskriftsartikel (216)
konferensbidrag (15)
rapport (1)
bok (1)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (214)
övrigt vetenskapligt/konstnärligt (20)
Författare/redaktör
Humphreys, K (154)
Hall, P (122)
Czene, K (119)
Chang-Claude, J (63)
Mannermaa, A (61)
Dunning, AM (60)
visa fler...
Easton, DF (60)
Fasching, PA (59)
Milne, RL (57)
Garcia-Closas, M (57)
Nevanlinna, H (56)
Southey, MC (55)
Schmidt, MK (55)
Chenevix-Trench, G (55)
Pharoah, PDP (54)
Margolin, S (53)
Beckmann, MW (53)
Benitez, J. (52)
Giles, GG (52)
Hamann, U (52)
Kosma, VM (52)
Blomqvist, C (51)
Cox, A (51)
Couch, FJ (51)
Andrulis, IL (50)
Bojesen, SE (50)
Brauch, H (49)
Eriksson, M (48)
Hopper, JL (48)
Devilee, P (48)
Hooning, MJ (47)
Flyger, H (47)
Burwinkel, B (46)
Lambrechts, D (46)
Peterlongo, P (45)
Aittomaki, K (45)
Dork, T (45)
Lindblom, A (44)
Ekici, AB (44)
Dennis, J (43)
Wang, Q. (43)
Guenel, P (43)
Nordestgaard, BG (43)
Kataja, V (43)
Jakubowska, A (43)
Anton-Culver, H (42)
Bolla, MK (42)
Truong, T (42)
Lissowska, J (42)
Lubinski, J (42)
visa färre...
Lärosäte
Karolinska Institutet (206)
Lunds universitet (31)
Uppsala universitet (30)
Chalmers tekniska högskola (8)
Umeå universitet (6)
Göteborgs universitet (5)
visa fler...
Stockholms universitet (5)
Linköpings universitet (5)
Kungliga Tekniska Högskolan (2)
Örebro universitet (2)
Karlstads universitet (2)
Mälardalens universitet (1)
Jönköping University (1)
Linnéuniversitetet (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (236)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (49)
Naturvetenskap (22)
Samhällsvetenskap (2)
Teknik (1)
Lantbruksvetenskap (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy